Cargando…
Discriminating agonist and antagonist ligands of the nuclear receptors using 3D-pharmacophores
Nuclear receptors (NRs) constitute an important class of therapeutic targets. We evaluated the performance of 3D structure-based and ligand-based pharmacophore models in predicting the pharmacological profile of NRs ligands using the NRLiSt BDB database. We could generate selective pharmacophores fo...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5011875/ https://www.ncbi.nlm.nih.gov/pubmed/27602059 http://dx.doi.org/10.1186/s13321-016-0154-2 |
_version_ | 1782451911407960064 |
---|---|
author | Lagarde, Nathalie Delahaye, Solenne Zagury, Jean-François Montes, Matthieu |
author_facet | Lagarde, Nathalie Delahaye, Solenne Zagury, Jean-François Montes, Matthieu |
author_sort | Lagarde, Nathalie |
collection | PubMed |
description | Nuclear receptors (NRs) constitute an important class of therapeutic targets. We evaluated the performance of 3D structure-based and ligand-based pharmacophore models in predicting the pharmacological profile of NRs ligands using the NRLiSt BDB database. We could generate selective pharmacophores for agonist and antagonist ligands and we found that the best performances were obtained by combining the structure-based and the ligand-based approaches. The combination of pharmacophores that were generated allowed to cover most of the chemical space of the NRLiSt BDB datasets. By screening the whole NRLiSt BDB on our 3D pharmacophores, we demonstrated their selectivity towards their dedicated NRs ligands. The 3D pharmacophores herein presented can thus be used as a predictor of the pharmacological activity of NRs ligands. [Figure: see text] ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13321-016-0154-2) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-5011875 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-50118752016-09-07 Discriminating agonist and antagonist ligands of the nuclear receptors using 3D-pharmacophores Lagarde, Nathalie Delahaye, Solenne Zagury, Jean-François Montes, Matthieu J Cheminform Research Article Nuclear receptors (NRs) constitute an important class of therapeutic targets. We evaluated the performance of 3D structure-based and ligand-based pharmacophore models in predicting the pharmacological profile of NRs ligands using the NRLiSt BDB database. We could generate selective pharmacophores for agonist and antagonist ligands and we found that the best performances were obtained by combining the structure-based and the ligand-based approaches. The combination of pharmacophores that were generated allowed to cover most of the chemical space of the NRLiSt BDB datasets. By screening the whole NRLiSt BDB on our 3D pharmacophores, we demonstrated their selectivity towards their dedicated NRs ligands. The 3D pharmacophores herein presented can thus be used as a predictor of the pharmacological activity of NRs ligands. [Figure: see text] ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13321-016-0154-2) contains supplementary material, which is available to authorized users. Springer International Publishing 2016-09-06 /pmc/articles/PMC5011875/ /pubmed/27602059 http://dx.doi.org/10.1186/s13321-016-0154-2 Text en © The Author(s) 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Lagarde, Nathalie Delahaye, Solenne Zagury, Jean-François Montes, Matthieu Discriminating agonist and antagonist ligands of the nuclear receptors using 3D-pharmacophores |
title | Discriminating agonist and antagonist ligands of the nuclear receptors using 3D-pharmacophores |
title_full | Discriminating agonist and antagonist ligands of the nuclear receptors using 3D-pharmacophores |
title_fullStr | Discriminating agonist and antagonist ligands of the nuclear receptors using 3D-pharmacophores |
title_full_unstemmed | Discriminating agonist and antagonist ligands of the nuclear receptors using 3D-pharmacophores |
title_short | Discriminating agonist and antagonist ligands of the nuclear receptors using 3D-pharmacophores |
title_sort | discriminating agonist and antagonist ligands of the nuclear receptors using 3d-pharmacophores |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5011875/ https://www.ncbi.nlm.nih.gov/pubmed/27602059 http://dx.doi.org/10.1186/s13321-016-0154-2 |
work_keys_str_mv | AT lagardenathalie discriminatingagonistandantagonistligandsofthenuclearreceptorsusing3dpharmacophores AT delahayesolenne discriminatingagonistandantagonistligandsofthenuclearreceptorsusing3dpharmacophores AT zaguryjeanfrancois discriminatingagonistandantagonistligandsofthenuclearreceptorsusing3dpharmacophores AT montesmatthieu discriminatingagonistandantagonistligandsofthenuclearreceptorsusing3dpharmacophores |